PT  - JOURNAL ARTICLE
AU  - Judith Leon
AU  - Anna E. Merrill
AU  - Kai Rogers
AU  - Julie Kurt
AU  - Spencer Dempewolf
AU  - Alexandra Ehlers
AU  - J. Brooks Jackson
AU  - C. Michael Knudson
TI  - SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
AID  - 10.1101/2021.07.30.21261339
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.30.21261339
4099  - http://medrxiv.org/content/early/2021/08/05/2021.07.30.21261339.short
4100  - http://medrxiv.org/content/early/2021/08/05/2021.07.30.21261339.full
AB  - Background and Objectives Vaccination has been shown to stimulate remarkably high antibody levels in donors who have recovered from COVID-19. Our objective was to examine patient antibody responses following COVID-19 Convalescent Plasma (CCP) transfusion and compare responses to CCP from vaccinated and nonvaccinated donors.Materials and methods Plasma samples were obtained from 25 recipients of CCP and COVID-19 antibody levels measured before and after CCP treatment. Factors that effect antibody levels were examined.Results In the 21 patients who received CCP from nonvaccinated donors, only modest increases in antibody levels were observed. Patients who received two units were more likely to seroconvert than those receiving just one unit. The strongest predictor of changes in patient antibody level was the CCP dose. Using patient plasma volume and donor antibody level, the post-transfusion antibody level could be predicted with remarkable accuracy. In contrast, the 4 patients who received CCP from vaccinated donors all had dramatic increases in antibody levels following transfusion of a single unit. In this subset of recipients, antibody levels observed after transfusion of CCP were comparable to those seen in donors who had fully recovered from COVID-19.Conclusion If available, CCP from vaccinated donors with very high antibody levels should be used. CCP from vaccinated donors increases patient antibody levels much more than 1 or 2 units of CCP from unvaccinated donors.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is not registered as it was not part of a clinical trial. Involved samples collected during the patients standard care.Funding StatementThere is no external funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Patients were recruited under a protocol approved by the Univ of Iowa IRB. Protocol #202004503All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified data from this study will be available upon request.